Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs NeoGenomics Inc. Common Stock (NEO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs NeoGenomics Inc. Common Stock — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $42.5 (market cap $7.04B), while NeoGenomics Inc. Common Stock trades at $16.83 (market cap $2.14B). The key difference: Ionis Pharmaceuticals Inc. Common Stock is far larger — about 3.3× NeoGenomics Inc. Common Stock's market cap, and NeoGenomics Inc. Common Stock is trading nearer its 52-week high, Ionis Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and NeoGenomics Inc. Common Stock for 0 Days on average.
| IONS | NEO | |
|---|---|---|
Market Cap | $7.04B | $2.14B |
Volume | 2,977,440 | 2,228,400 |
Sector | Health | Health |
52-Week High | $86.50 | $19.91 |
52-Week Low | $42.38 | $7.19 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $6.60B | $2.44B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About NeoGenomics Inc. Common Stock
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →
